Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1545-2020

Drug recall · September 2, 2020

Losartan Potassium Tablets USP recall

Why: Failed Tablet/Capsule Specification; complaint of bulging tablet

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India

Lots / codes

Batch # LOA19357A, exp. date 09/2021

Quantity
43,512 bottles
Company
Hetero Labs Limited (Unit V), Badepalle, N/A
Distribution
Product was distributed to major wholesalers/distributors throughout the United States.
Initiated
August 6, 2020 · Voluntary: Firm initiated
Classified
August 26, 2020
Reported
September 2, 2020
Ended
January 24, 2022
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Losartan

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.